Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.39
+0.34 (3.38%)
At close: Mar 9, 2026, 4:00 PM EDT
10.37
-0.02 (-0.19%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Design Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 592 | 349 | 148 | 573 | 1,183 | - | |
| Market Cap Growth | 108.64% | 135.41% | -74.10% | -51.55% | - | - | |
| Enterprise Value | 388 | 98 | -139 | 233 | 793 | - | |
| Last Close Price | 10.05 | 6.17 | 2.65 | 10.26 | 21.41 | - | |
| PB Ratio | 2.87 | 1.44 | 0.53 | 1.75 | 3.10 | - | |
| P/TBV Ratio | 2.96 | 1.44 | 0.53 | 1.75 | 3.10 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | |
| Net Debt / Equity Ratio | -1.02 | -1.00 | -1.00 | -1.00 | -1.00 | -1.06 | |
| Net Debt / EBITDA Ratio | 2.65 | 3.94 | 3.59 | 4.86 | 10.66 | 4.34 | |
| Net Debt / FCF Ratio | 3.90 | 5.60 | 4.74 | 6.25 | 12.31 | 4.13 | |
| Asset Turnover | - | - | - | - | - | 0.01 | |
| Quick Ratio | 18.56 | 29.16 | 29.44 | 30.76 | 72.72 | 15.49 | |
| Current Ratio | 18.71 | 29.31 | 29.58 | 31.10 | 72.96 | 15.55 | |
| Return on Equity (ROE) | -29.83% | -19.08% | -22.10% | -17.85% | -17.08% | -54.47% | |
| Return on Assets (ROA) | -20.49% | -14.39% | -15.50% | -11.55% | -10.49% | -28.44% | |
| Return on Capital Employed (ROCE) | -38.70% | -25.60% | -27.90% | -20.50% | -9.30% | -24.40% | |
| Earnings Yield | -11.40% | -14.19% | -45.05% | -11.05% | -3.00% | - | |
| FCF Yield | -8.86% | -12.44% | -39.63% | -9.12% | -2.61% | - | |
| Buyback Yield / Dilution | -0.66% | -1.08% | -0.50% | -21.27% | -190.80% | -2.08% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.